William P. Hendricks, Ph.D.
Affiliations: | 2012 | Johns Hopkins University, Baltimore, MD |
Area:
Biomedical Engineering, Molecular BiologyGoogle:
"William Hendricks"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Bert Vogelstein | grad student | 2012 | Johns Hopkins | |
| (A novel nanoparticle formulation hunts down metastatic tumors.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sakthikumar S, Warrier M, Whitley D, et al. (2023) Genomic analysis across 53 canine cancer types reveals novel mutations and high clinical actionability potential. Veterinary and Comparative Oncology |
| Ghergurovich JM, O’Shaughnessy J, Levin MK, et al. (2020) Abstract P3-02-06: Tracing glucose catabolism in human triple negative breast cancer tumors Cancer Research. 80 |
| Wang T, Gonzales P, Kotlarczyk K, et al. (2019) Abstract LB-058: GB-3103, an epigenetic immunomodulator, shows potent antitumor activity against tumors harboring dual loss of SMARCA4/SMARCA2 ATPases Cancer Research. 79 |
| Soldi R, Weston A, Thode T, et al. (2019) Abstract 3869: The reversible LSD1 inhibitor SP-2509 promotes anti-tumor immunity in small cell carcinoma of the ovary-hypercalcemic type (SCCOHT) Cancer Research. 79: 3869-3869 |
| Lorch G, Sivaprakasam K, Zissman V, et al. (2019) Abstract 3705: Identification of frequent HER2 activating mutations in canine primary pulmonary adenocarcinoma Cancer Research. 79: 3705-3705 |
| Gardner HL, Sivaprakasam K, Briones N, et al. (2019) Abstract B026: The genomic landscape of canine osteosarcoma implicates DMD as a therapeutic vulnerability Molecular Cancer Therapeutics. 18 |
| Lorch G, Zismann V, Perdigones N, et al. (2019) P2.14-10 Identification of Frequent, Activating HER2 Mutations and HER2 Inhibitor Response and Resistance in Canine Lung Cancer Journal of Thoracic Oncology. 14 |
| Kraveka J, Brown V, Ferguson W, et al. (2018) Abstract CT073: Peds-plan, pediatric precision laboratory advanced neuroblastoma therapy: Molecular guided therapy for high risk neuroblastoma at diagnosis Clinical Trials. 78 |
| Wang Y, Chen SY, Colborne S, et al. (2018) Abstract 3673: Targeting the epigenome of small cell hypercalcemic carcinoma of the ovary, hypercalcemic type (SCCOHT) Cancer Research. 78: 3673-3673 |
| Liang WS, Hendricks W, Kiefer J, et al. (2017) Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma. Genome Research. 27: 524-532 |